查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606662

DNA/基因晶片市场：按产品类型、阵列类型、应用和最终用户 - 2025-2030 年全球预测

DNA & Gene Chip Market by Product (Consumables, Instruments), Array Type (cDNA-Based Microarray, Oligonucleotide-Based Microarray), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年DNA和基因晶片市值为87.7亿美元，预计2024年将达到97.1亿美元，复合年增长率为11.34%，预计到2030年将达到186.1亿美元。

DNA 和基因晶片市场是生物技术和基因组学领域的一个专门领域，专注于促进基因表现和遗传变异快速分析的技术。这些晶片也称为微阵列，是推动个人化医疗、诊断和治疗方法开发的重要工具。需要的是实现大规模基因组研究、加速药物发现并提高对疾病的了解。应用涵盖肿瘤学、药物基因组学、遗传分析和农业生物技术，为实验室、医院和生物製药公司等广泛的最终用户提供服务。市场的主要驱动力是个人化医疗需求的不断增长、技术进步带来的成本效率和高通量性能以及生物技术行业的扩张。此外，越来越多的遗传性疾病和癌症患者需要高效的诊断工具，这提供了潜在的成长机会。

主要市场统计
基准年[2023] 87.7亿美元
预测年份 [2024] 97.1亿美元
预测年份 [2030] 186.1亿美元
复合年增长率（%） 11.34%

然而，成长也存在障碍，例如与技术相关的高成本以及由于产生大量资讯而导致的资料管理挑战。智慧财产权问题也是一个障碍。开拓新兴市场、增强资料分析技术和整合人工智慧等机会提供了强大的成长途径。公司应专注于开发中小型企业负担得起且易于使用的微阵列解决方案。此外，扩大农业应用，例如作物改良和动物遗传学，可以开拓新的收益来源。

创新的关键是投资开发能够简化资料解释并提高准确性的平台。此外，重点可能是将微阵列技术与 CRISPR 和次世代定序仪相结合，以改善诊断和治疗策略。了解以快速技术变革和严格监管政策为特征的竞争格局，有助于公司在市场中策略定位。 DNA和基因晶片市场潜力巨大，预计将稳定成长，但企业需要有效应对挑战，利用技术进步来抓住新机会。

市场动态：快速发展的 DNA 和基因晶片市场的关键市场洞察

DNA/基因晶片市场正因供需的动态互动而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 用于遗传分析和诊断的 DNA 和基因晶片的需求不断增长
    • 个人化医疗在癌症治疗中的快速采用
    • 对早期癌症检测和癌症诊断的需求不断增加
  • 市场限制因素
    • 缺乏技术精湛、经验丰富的专业人员
  • 市场机会
    • DNA/基因晶片小型化研究进展
    • DNA 和基因晶片的政府策略资助和倡议
  • 市场挑战
    • 对基因表现调控和替代技术可用性的担忧

波特五力：驾驭 DNA 与基因晶片市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解DNA/基因晶片市场的外部影响

外部宏观环境因素在塑造 DNA 和基因晶片市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 DNA/基因晶片市场的竞争状况

DNA 和基因晶片市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵DNA及基因晶片市场厂商绩效评估

FPNV定位矩阵是评估DNA和基因晶片市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘 DNA 和基因晶片市场的成功之路

DNA 和基因晶片市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告提供了涵盖关键重点领域的市场全面分析：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 用于遗传分析和诊断的 DNA/基因晶片的需求不断增加
      • 个人化医疗在癌症治疗中的快速引入
      • 对癌症早期检测和诊断的需求不断增加
    • 抑制因素
      • 缺乏技术精湛、经验丰富的专业人员
    • 机会
      • DNA/基因晶片小型化的到来
      • 关于 DNA 和基因晶片的政府策略资助和倡议
    • 任务
      • 对基因表现控制和替代技术可用性的担忧
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 DNA/基因晶片市场：副产品

  • 消耗品
  • 装置

第7章依序列类型分類的DNA/基因晶片市场

  • 基于 cDNA 的微阵列
  • 基于寡核苷酸的微阵列

第八章 DNA/基因晶片市场：依应用分类

  • 诊断
  • 药物发现与开发
  • 基因组学
  • 个人化医疗

第 9 章 DNA/基因晶片市场：依最终用户分类

  • 学术研究所
  • 医院和临床实验室
  • 製药和生物技术公司

第10章美洲DNA/基因晶片市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太DNA/基因晶片市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲的DNA和基因晶片市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 23andMe, Inc.
  • Agilent Technologies, Inc.
  • Arrayit Corporation
  • Biomerieux SA
  • Bioneer Corporation
  • CapitalBio Technology Co., Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Greiner Bio-One International GmbH
  • Illumina, Inc.
  • Integrated Dna Technologies
  • LifeGen Technologies, LLC
  • Macrogen Inc.
  • Merck KGaA
  • Microarrays Inc.
  • Ocimum Biosolutions Ltd.
  • Perkin Elmer, Inc.
  • Promega Corporation
  • Savyon Diagnostics
  • Scienion AG by a Bico Company
  • Shanghai Biochip Co Ltd.
  • Sophia Genetics SA
  • Surmodics Inc.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation
  • Veritas Genetics, Inc.
Product Code: MRR-521BAA36EBAB

The DNA & Gene Chip Market was valued at USD 8.77 billion in 2023, expected to reach USD 9.71 billion in 2024, and is projected to grow at a CAGR of 11.34%, to USD 18.61 billion by 2030.

The DNA and Gene Chip market represents a specialized segment within the biotechnology and genomics field, focusing on technology facilitating the rapid analysis of gene expression and genetic variations. These chips, also called microarrays, are indispensable tools for advancing personalized medicine, diagnostics, and therapeutic development. Their necessity lies in enabling large-scale genomic research, accelerating drug discovery, and enhancing disease understanding. Applications span across oncology, pharmacogenomics, genetic analysis, and agricultural biotechnology, serving a wide range of end-users, including research labs, hospitals, and biopharmaceutical companies. The market is predominantly driven by the increasing demand for personalized medicine, technological advancements leading to cost-effective and high-throughput capabilities, and the expanding biotech industry. Furthermore, the rise in genetic disorders and cancer cases necessitates efficient diagnostic tools, providing potential growth opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 8.77 billion
Estimated Year [2024] USD 9.71 billion
Forecast Year [2030] USD 18.61 billion
CAGR (%) 11.34%

However, certain growth barriers include the high costs associated with technology and data management challenges due to the vast amount of information generated. Intellectual property issues also present obstacles. Opportunities for tapping into emerging markets, enhancing data analysis techniques, and integrating artificial intelligence present significant avenues for growth. Companies should focus on developing affordable and user-friendly microarray solutions to cater to small and medium-sized enterprises. Moreover, expanding applications in agriculture for crop improvement and animal genetics could open new revenue streams.

For innovation, investing in platform development that simplifies data interpretation and enhances accuracy will be key. Moreover, research could focus on combining microarray technology with CRISPR and next-generation sequencing for improved diagnostics and treatment strategies. Understanding the competitive landscape, marked by rapid technological shifts and stringent regulatory policies, can aid businesses in strategically positioning themselves in the market. With a robust growth outlook, the DNA and Gene Chip market holds substantial potential, but companies need to effectively address challenges and leverage technological advancements to capitalize on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving DNA & Gene Chip Market

The DNA & Gene Chip Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need of DNA & gene chip for genetic analysis and diagnostics
    • Surging adoption of personalized medicines for cancer treatments
    • Increase in the demand for early cancer detection and cancer diagnosis
  • Market Restraints
    • Lack of skilled and experienced subject experts
  • Market Opportunities
    • Emerging miniaturization of DNA & gene chip
    • Strategic government fundings and initiatives for DNA & gene chip
  • Market Challenges
    • Concern associated with gene expression regulation and availability of alternative technologies

Porter's Five Forces: A Strategic Tool for Navigating the DNA & Gene Chip Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the DNA & Gene Chip Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the DNA & Gene Chip Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the DNA & Gene Chip Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the DNA & Gene Chip Market

A detailed market share analysis in the DNA & Gene Chip Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the DNA & Gene Chip Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the DNA & Gene Chip Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the DNA & Gene Chip Market

A strategic analysis of the DNA & Gene Chip Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the DNA & Gene Chip Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Agilent Technologies, Inc., Arrayit Corporation, Biomerieux SA, Bioneer Corporation, CapitalBio Technology Co., Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Greiner Bio-One International GmbH, Illumina, Inc., Integrated Dna Technologies, LifeGen Technologies, LLC, Macrogen Inc., Merck KGaA, Microarrays Inc., Ocimum Biosolutions Ltd., Perkin Elmer, Inc., Promega Corporation, Savyon Diagnostics, Scienion AG by a Bico Company, Shanghai Biochip Co Ltd., Sophia Genetics SA, Surmodics Inc., Sysmex Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, and Veritas Genetics, Inc..

Market Segmentation & Coverage

This research report categorizes the DNA & Gene Chip Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments.
  • Based on Array Type, market is studied across cDNA-Based Microarray and Oligonucleotide-Based Microarray.
  • Based on Application, market is studied across Diagnostics, Drug Discovery & Development, Genomics, and Personalized Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospitals & Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need of DNA & gene chip for genetic analysis and diagnostics
      • 5.1.1.2. Surging adoption of personalized medicines for cancer treatments
      • 5.1.1.3. Increase in the demand for early cancer detection and cancer diagnosis
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled and experienced subject experts
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging miniaturization of DNA & gene chip
      • 5.1.3.2. Strategic government fundings and initiatives for DNA & gene chip
    • 5.1.4. Challenges
      • 5.1.4.1. Concern associated with gene expression regulation and availability of alternative technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. DNA & Gene Chip Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments

7. DNA & Gene Chip Market, by Array Type

  • 7.1. Introduction
  • 7.2. cDNA-Based Microarray
  • 7.3. Oligonucleotide-Based Microarray

8. DNA & Gene Chip Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics
  • 8.3. Drug Discovery & Development
  • 8.4. Genomics
  • 8.5. Personalized Medicine

9. DNA & Gene Chip Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospitals & Clinical Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas DNA & Gene Chip Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific DNA & Gene Chip Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa DNA & Gene Chip Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Agilent Technologies, Inc.
  • 3. Arrayit Corporation
  • 4. Biomerieux SA
  • 5. Bioneer Corporation
  • 6. CapitalBio Technology Co., Ltd.
  • 7. Eurofins Scientific SE
  • 8. F. Hoffmann-La Roche AG
  • 9. Greiner Bio-One International GmbH
  • 10. Illumina, Inc.
  • 11. Integrated Dna Technologies
  • 12. LifeGen Technologies, LLC
  • 13. Macrogen Inc.
  • 14. Merck KGaA
  • 15. Microarrays Inc.
  • 16. Ocimum Biosolutions Ltd.
  • 17. Perkin Elmer, Inc.
  • 18. Promega Corporation
  • 19. Savyon Diagnostics
  • 20. Scienion AG by a Bico Company
  • 21. Shanghai Biochip Co Ltd.
  • 22. Sophia Genetics SA
  • 23. Surmodics Inc.
  • 24. Sysmex Corporation
  • 25. Thermo Fisher Scientific Inc.
  • 26. Twist Bioscience Corporation
  • 27. Veritas Genetics, Inc.

LIST OF FIGURES

  • FIGURE 1. DNA & GENE CHIP MARKET RESEARCH PROCESS
  • FIGURE 2. DNA & GENE CHIP MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DNA & GENE CHIP MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DNA & GENE CHIP MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DNA & GENE CHIP MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DNA & GENE CHIP MARKET DYNAMICS
  • TABLE 7. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DNA & GENE CHIP MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DNA & GENE CHIP MARKET SIZE, BY CDNA-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DNA & GENE CHIP MARKET SIZE, BY OLIGONUCLEOTIDE-BASED MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DNA & GENE CHIP MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DNA & GENE CHIP MARKET SIZE, BY GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DNA & GENE CHIP MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DNA & GENE CHIP MARKET SIZE, BY HOSPITALS & CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DNA & GENE CHIP MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES DNA & GENE CHIP MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA DNA & GENE CHIP MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY ARRAY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM DNA & GENE CHIP MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. DNA & GENE CHIP MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. DNA & GENE CHIP MARKET, FPNV POSITIONING MATRIX, 2023